Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
JTO Clin Res Rep
.
2020 Apr 28;1(3):100046.
doi: 10.1016/j.jtocrr.2020.100046.
eCollection 2020 Sep.
Authors
Kageaki Watanabe
1
,
Rui Kitadai
1
,
Shingo Kitagawa
1
,
Takashi Toya
1
,
Yukio Hosomi
1
Affiliation
1
Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
PMID:
34589942
PMCID:
PMC8474194
DOI:
10.1016/j.jtocrr.2020.100046
No abstract available
Publication types
Case Reports